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SHORT REPORT 
Lung Cancer Risk Is Proportional to Cigarette Tar Yield: 
Evidence from a Prospective Study 
STEVEN D. STELLMAN,PH.D.'AND LAWRENCEGARFINKEL, M.A. 
Department of Epidemiology and Statistics, American Cancer Society, 1180 Avenue of the 
Americas, New York, New York 10036 
The age-adjusted risk for lung cancer among over 120,000 male current cigarette smokers 
in the American Cancer Society’s 1959-1972 prospective study was analyzed according to 
tar yield and quantity smoked per day. At each quantity level, the risk increased with 
increasing tar yield, and at each tar level, the risk increased with numbers of cigarettes 
smoked daily. The risks in smokers of cigarettes with the lowest yields, however, far 
exceeded those of former smokers and nonsmokers. The excess lung cancer risk for current 
smokers was directly proportional to the estimated total milligrams of tar consumed daily: 
SMR = 100 + 1.731 x milligrams tar per day. Tar yields today are much lower than they 
were at the time of this study and presage an eventual reduction (but not elimination) of lung 
cancer risk for those who continue to smoke cigarettes, especially among lifetime smokers 
of low-tar cigarettes. 6 1989 Academic Press, Inc. 
INTRODUCTION 
The carcinogenic potential of cigarette smoke is now believed to reside mainly 
in the particulate matter or tar (1). Numerous studies over the years have dem- 
onstrated that the risk for lung and other cancers among cigarette smokers, rel- 
ative to nonsmokers, varies with the tar yield (2). This relationship has been 
consistently observed, despite varied representations of tar yield, which have 
ranged from classifying cigarettes as filter or nonfilter (3), to fairly elaborate 
schemes based on machine-rated yields and other smoker characteristics (4). 
There have been very few attempts to present classical dose-response curves in 
relation to tar yields (5) that would allow a visual quantification of relative risk. 
Opportunities for measuring such curves in Western populations are fading, as the 
distribution of cigarette yields becomes compressed at the low end of the spec- 
trum. We present here a new analysis of data originally collected by the American 
Cancer Society in its prospective study conducted from 1959 to 1972. Hammond 
et al. (6) had previously shown that lung cancer risk was greater in both men and 
women who smoked “high tar/nicotine” cigarettes in this population, but in order 
to emphasize this point, data were adjusted for quantity smoked, and the dose- 
response relationship by tar yield within categories of amount smoked was not 
shown. In the following analysis, we demonstrate that tar yield operates indepen- 
dently of daily quantity smoked and that lung cancer risk increases roughly in 
proportion to the machine-derived dosage of tar consumed daily. 
’ To whom reprint requests should be addressed at Division of Biostatistics and Epidemiologic 
Research, Box 22, New York City Department of Health, 125 Worth Street, New York, NY 10013. 
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METHODS AND MATERIALS 
The data are from Cancer Prevention Study I (CPS-1),2 details of which have 
been presented previously (7-10). Between October 1, 1959, and March 31, 1960, 
volunteer workers of the American Cancer Society enrolled over 1,000,000 men 
and women in a prospective mortality study. The volunteers successfully traced 
98.4% of the subjects through September 30, 1971. This article is based upon 
information recorded in the initial baseline questionnaire, and follow-up is con- 
fined to experience during the time period July 1, 1960 to June 30, 1966. The 
analysis is restricted to white males with no self-reported history of cancer, heart 
disease, or stroke, and who answered “No” to the question “Are you sick at the 
present time.” These exclusions serve to eliminate very ill persons from the 
study, so that follow-up pertains largely to an initially healthy population. To 
reduce confounding by socioeconomic status, which is associated with both 
choice of cigarette brand and with mortality, analysis was further restricted to 
men who had completed at least some high school. 
Mortality data were confined to the first 6 years of the study so as to minimize 
the effect upon death rates of well-documented reductions in cigarette smoking 
habits in this population (11). In addition, during the first 6 years of follow-up 
additional information was sought from doctors and hospitals whenever cancer 
was mentioned on death certificates, so that mortality information is based upon 
best evidence of cause of death. 
Information on the tar content of the smoke from various brands of cigarettes 
was obtained from several sources (6), including analyses released by Foster D. 
Snell, Inc., and published in the Reader’s Digest in 1959 and 1961. Each subject 
was classified according to the tar content (H, high; M, medium; L, low) of the 
cigarette brand he usually smoked at the time of the initial questionnaire. Under 
this categorization, high T/N cigarettes contained 25.7 to 35.7 mg of tar, medium 
T/N cigarettes contained 17.7 to 25.6 mg, and low T/N had yields up to 17.6 mg. 
Current smokers of cigarettes at time of enrollment were classified jointly ac- 
cording to their tar level and the number of cigarettes smoked per day, recorded 
categorically as l-19,20,21-39, or 40 or more cigarettes per day, making 4 x 3 = 
12 categories in all. Former smokers of cigarettes were placed in a separate 
category. Men who had never smoked regularly (nonsmokers) were also included 
for comparison. The largest single category of smokers consumed 20 medium tar 
cigarettes per day; this group was therefore considered the reference category. 
All analyses were stratified by 5-year age groups; since subjects were enrolled 
at about the same time, this also amounts to stratification by birth cohort. Fur- 
thermore, the age at which subjects began to smoke cigarettes showed similar 
distributions in all age groups, with the majority in a fairly narrow band around 
15-19 years (8). Duration of smoking habit in this population is thus closely 
correlated with age, so that adjustment for age tends to result in adjustment for 
duration as well. Therefore, no further adjustment for duration of smoking habit 
’ Abbreviations used: CPS-I, Cancer Prevention Study I; CPS-2, Cancer Prevention Study II; T/N, 
tar/nicotine yield; SMR, standardized mortality ratio. 
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was made. It is also nearly certain that the 20-year latency period for tobacco- 
induced lung cancer had already elapsed for practically all smokers in this study 
by the time of enrollment. 
Age-, tar-, and quantity-specific lung cancer death rates were computed by 
dividing the number of lung cancer deaths by the person-years of exposure in each 
stratum. Expected numbers of deaths in each tar-quantity stratum were obtained 
by multiplying the number of person-years in that stratum by the corresponding 
lung cancer death rate in the 20 cigarette per day/medium T/N reference group and 
summing over age strata. The standardized mortality ratio within each tar- 
quantity group was formed by first dividing 100 times observed deaths by the 
expected number of deaths within that group, then dividing the result by 0.095, 
which is the ratio of observed to expected deaths in nonsmokers, whose SMR 
thereby becomes 100. This expedient, which is merely a shift of scale, does not 
affect relative comparisons and allows SMRs to be expressed relative to the more 
“natural” nonsmoker reference group. 
RESULTS 
There were 969 deaths from lung cancer during the 6 years of follow-up, in a 
population of 222,830 men who met the above restrictions (Table 1). Of these men, 
120,583 (54.1%) were current smokers, 40,827 (18.3%) had not smoked cigarettes 
for at least 1 year, and 61,420 (27.6%) had never smoked. Among current smok- 
ers, at each T/N level, the SMR increased with quantity (Table 2), while at each 
value of daily quantity smoked, the SMR for the high T/N cigarette smokers 
exceeded that for the medium group, which in turn exceeded the low group SMRs 
(except at the lowest quantity, where the medium T/N SMR slightly exceeded the 
high T/N SMR). Lifetime nonsmokers had lung cancer death rates well below any 
group of current smokers, irrespective of cigarette yield. Ex-smokers’ rates were 
intermediate between those of current smokers and nonsmokers. 
The final column of Table 2 shows observed and expected lung cancer deaths 
summed across the quantity columns. The SMRs in that column can be consid- 
ered adjusted for both age and quantity smoked. These SMRs, which are shown 
in Fig. 1 along with their 95% confidence intervals, progress from 841 among low 
TABLE 1 
SUBJECTS, PERSON-YEARS, AND LUNG CANCER DEATHS ACCORDING TO SMOKING HABITS 
No. subjects Person-years 
No. lung 
cancer deaths 








61,420 351,070 51 
40,827 232,661 94 
120,583 678,992 824 
17,556 99,487 93 
56,718 319,630 380 
46,309 259,875 351 
222,830 1,262,723 %9 
Note. Low, up to 17.6 mg tar; Medium, 17.7 to 25.6 mg tar; High, 25.7 to 35.7 mg tar. 
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TABLE 2 
EXPECTED” AND OBSERVED DEATHS AND STANDARDIZED MORTALITY RATIOS FOR LUNG CANCER 
ACCORDING TO CIGARETTE YIELD AND NUMBER OF CIGARETTES SMOKED PER DAY 






























Number of cigarettes smoked per day 
I-19 20 21-39 ‘IO+ 
z.2 ::.7 25 16 
24.2 15.3 
524 911 1086 1100 
87 131 95 66 
119.1 131.0 70.1 38.1 
768 1053 1414 1824 
62 140 88 60 
1.0 115.0 59.4 32.1 
117 1281 1560 1930 
169 303 208 142 
250.3 282.7 154.3 86.1 














Note. Abbreviations: SMR, standardized mortality ratio; TM, tar/nicotine yield. 
a Expected numbers of deaths are based on age-specific lung cancer rates for smokers of 20 Medium T/N cigarettes 
per day. 
b SMR = 100 X (Observed/Expected) + 0.095 in order to make the SMR for nonsmokers 100. 
c Low, to 17.6 up mg tar; Medium, 17.7 to 25.6 tar; High, mg 25.7 to 35.7 mg tar. 
T/N smokers to 1,112 for medium and up to 1,236 for the high group. The SMR for 
high T/N smokers was significantly higher than that of the low group (P < 0.05). 
Within each of these T/N groupings regression lines were fitted to the expres- 
sion SMR = 100 + B X number cigarettes per day. Due to coding of categorical 
cigarette quantities (1-19, 21-39, 40+), exact abscissas were not known for this 
population. To represent the “average” number of cigarettes per day at each of 
these levels, we used as abscissas the actual average values within those catego- 
ries for male current smokers from Cancer Prevention Study 2 (CPS-2) (12), in 
which the exact number of cigarettes smoked per day is known. These average 
values are 1-19 cigarettes, 9.28; 21-39 cigarettes, 29.17; and 40+ cigarettes, 
44.23. To the extent by which the CPS-1 population (surveyed in 1959) and CPS-2 
(surveyed in 1982) differ in these averages, the curves will be in error. 
The slopes of the regression lines with their 95% confidence intervals are pre- 
sented in Table 3. Regressions were weighted by the number of lung cancer deaths 
at each point. The slope of the high T/N curve significantly exceeded that of the 
medium T/N curve, which in turn significantly exceeded that of the low T/N 
curve. 
In a separate view of the same data, a daily “tar dosage” was computed for 
each individual smoker by multiplying his assigned number of cigarettes smoked 
per day (9.28,20.00,29.17, or 44.23) by estimated tar levels of 16.5 mg for low T/N 
smokers, 2 1 .O mg for medium T/N smokers, and 3 1 .O mg for high T/N smokers. 
These values are weighted averages of tar yields within each of the three T/N 






0 1 I I 
.LOW’ “Medium” ‘High” 
Up to 17.6 Mg 17.7-25.6 Hg Z%TMgcim~re 
TAR YIELD OF CURRENT BRAND 
FIG. 1. Standardized mortality ratio for lung cancer among male current smokers according to tar 
yield of current brand, adjusted for age and number of cigarettes smoked daily, shown with 95% 
confidence intervals. 
categories, based upon machine-derived yields measured in the late 1950s and 
brand distributions of study subjects. The SMRs are plotted against these putative 
dosages in Fig. 2 and appear to lie on a straight line, except for the highest dosage 
point. These data were fitted to a dose-response curve: SMR = 100 + 1.731 x 
milligrams tar per day (standard error of the slope = 0.012). 
DISCUSSION 
The literature on cancer risk in relation to cigarette yield has been reviewed 
recently (2). In numerous case-control and prospective studies performed in the 
United States and Europe, the relative risk for lung cancer has consistently been 
found to be lower among both men and women who smoke lower-yield cigarettes. 
This basic finding held irrespective of the many different ways in which “dosage” 
was expressed, whether in qualitative filter vs nonfilter analyses, such as those of 
Wynder and Stellman (3) and Benhamou et al. (13), or quantitatively, using ex- 
TABLE 3 
REGRESSION COEFFICIENTS, B, AND 95% CONFIDENCE INTERVALS FOR THE EQUATION 
SMR = 100 + B x (No. CIGARETTES PER DAY) 




30.2 (28.7, 31.8) 
43.4 (42.8, 44.0) 
48.4 (47.6, 49.2) 
Note. Low, up to 17.6 mg tar; Medium, 17.7 to 25.6 mg tar; High, 25.7 to 35.7 mg tar. 
D Each data point is weighted by the number of lung cancer deaths at that T/N quantity level. 
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FIG. 2. Standardized mortality ratio for lung cancer among male current smokers according to the 
daily tar consumption (estimated as machine-rated yield of usual brand times average No. of cigarettes 
smoked daily). 
plicit tar yields or ranges, as in the study by Vutuc and Kunze (4). A similar 
conclusion was reached by an international workshop on low tar-yield cigarettes 
(14). Risks for other cancers besides the lung, notably larynx (3), esophagus (15), 
and bladder (16), have also been found to be lower among smokers of filter 
cigarettes than among smokers of nontilters. 
The data presented here are consistent with prior reports (2) implicating tar as 
the main carcinogenic agent in cigarette smoke and furthermore suggest a linear 
dose-response relationship. The quantitative model presented, while idealized 
through reference to machine-measured yields and use of an age-adjusted end- 
point, seems a plausible approximation for a dose-response and also suggests a 
way of quantifying potential risk reduction. Under this model, a slope of 1.731 per 
milligram tar per day translates to a relative risk of 7.9 for a smoker of one pack 
of cigarettes with a 20-mg (machine-measured) yield daily, compared with 4.4 for 
a smoker of one pack of cigarettes with a lo-mg yield. This is, of course, the 
maximum risk reduction that could be expected by a person halving his yield, 
since it does not explicitly account for latency; one who switches from a higher to 
a lower yield cigarette can at best expect a gradual, not instantaneous, risk re- 
duction. 
The tar yields to which this cohort has been exposed are extremely high by the 
standards of today’s American marketplace, and one hopes they will never again 
be this high. Between 1950 and 1980, the sales-weighted average tar yield deliv- 
ered by U.S. cigarettes declined from 37 mg to about 15 mg (17, 18). There are 
very few smokers in the United States today who consume cigarettes approaching 
even the median yield of CPS-1. In the successor to the study described here, 
CPS-2, which was begun in 1982 (12), the mean tar yield for current smokers 
524 STELLMAN AND GARPINKEL 
amongmenwas 138mgandamongwomenwas 11.8mg;71.6%ofmenand81.8% 
of women were currently smoking cigarettes with less than 16.2 mg tar. 
The effect which this overall decline in machine-measured tar yields will have 
on lung cancer rates is of great interest, but is quite difficult to evaluate. In the 
United States, where lung cancer incidence rates for both men and women had 
been rising for several decades, the rate of increase for men has diminished in 
recent years, and the actual incidence rates have in fact declined among men ages 
35-44 and 45-54 years since about 1980 (19). Some proportion of the decrease is 
undoubtedly due to cessation of smoking by selected segments of the population 
(20), but this is unlikely to have had much influence on rates in the younger 
groups. Overall rates among men have already begun to fall in the United King- 
dom (21), and Peto has argued that an approximate halving of lung cancer death 
rates among British men in “early middle age” (ages 30-54 years) between 1963 
and 1983 may be closely linked to a similar decrease in tar deliveries there (22). 
Another problem affecting prediction of long-term effects of lower-tar cigarettes 
on lung cancer rates is the phenomenon of “compensation,” or behavioral ad- 
justment by smokers of lower-yield cigarettes in favor of greater puff frequency, 
deeper inhalation, and consumption of greater numbers of cigarettes (18). To the 
extent that smokers of lower-tar cigarettes increase their physiologic dosage of 
carcinogenic components, apparent differences in risk between low- and high-tar 
cigarette smokers will tend to diminish. Fortunately, compensation-related errors 
are much less likely to affect smoking studies in populations such as CPS-1, where 
the range of tar yields is extremely wide, than those in modem-day populations 
whose exposures cover a much narrower range. Furthermore, many of today’s 
long-term smokers still have had significant exposures during their lifetimes to the 
high-tar cigarettes described here. Analysis of lung cancer mortality in CPS-2 is 
expected to document whether rates will decrease in such smokers (12), but 
studies of lung cancer rates in life-time smokers of cigarettes having yields below 
10 mg cannot yet be made, since these cigarette brands have only been smoked by 
large numbers of people for less than 10 years. 
Regrettably, the tobacco industry has seen fit to market high-tar brands in less 
developed countries (1). Consequently, the dose-response curves demonstrated 
in this study may still be relevant in other parts of the world and may be of special 
interest to agencies engaged in programs of cancer control in those countries. 
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